As an investor in Pfizer (NYSE: PFE ), one of the world's largest pharmaceutical companies, I am marginally disappointed, as other investors would be, that the company had another underwhelming year on the stock markets.Uttam is a growth-oriented investment analyst whose equity research primarily focuses on the technology sector. Semiconductors, Artificial Intelligence and Cloud software are some of the key sectors that are regularly researched and published by him. His research also focuses on other areas ...